Skip to content
Raw Biologic Ingredient

HMSC ExoPearls™
Biologics

Pharmaceutical-grade human mesenchymal stem cell-derived exosomes in a proprietary cryo-formed sphere format. ExoPearls™ are the world's first exosome biologic produced as a precision-formed solid sphere - not lyophilised powder. Instant dissolution in saline. Supplied to licensed practitioners and research institutions worldwide.

Exosomes are nanoscale vesicles secreted by stem cells - the signalling particles that direct tissue repair, immune modulation, and cellular regeneration.

10B+ Exosomes / pearl
12mo Ambient shelf life
GMP Certified source
HK Incorporated
Active Batch · BX-241
HMSC ExoPearls™
2-Sphere Vial
BEXO ExoPearls™ cryo-formed exosome vial - 2-sphere format with ambient stability
Each sphere: ≥ 10 billion exosomes · Ambient stable
SourceVerified donor HMSC · Wharton's Jelly
Concentration≥ 10 billion exosomes / sphere
ReconstitutionInstant dissolution in saline
StorageAmbient temperature · 12 months
SterilityUSP <71> confirmed per batch
Endotoxin< 0.1 EU/mL post-reconstitution
RegistrationBEXO Ltd · Hong Kong SAR
GMP Certified Source USP <71> Sterility Confirmed Xeno-Free Ambient Stable · 12 Months HK Incorporated
Molecular Cargo · Confirmed per batch
HMSC Exosome
Biological Profile
  • CD9 · CD63 · CD81 tetraspanins - surface identity confirmed
  • Growth factors: EGF, FGF, VEGF, IGF-1, TGF-β
  • Anti-inflammatory miRNA: miR-21 · miR-146a
  • Neuroprotective cargo: BDNF · GDNF signalling molecules
  • Wnt pathway modulators - follicular regeneration
  • Immunomodulatory factors: IL-10 · TSG-6 pathway
  • Angiogenic mediators - tissue vascularisation
  • Extracellular matrix repair proteins
ExoPearl™ Technology

Cryo-formed spheres -
a distinct format.

Purified HMSC exosomes cryo-formed into solid spheres via a patented cryo-forming process developed by our manufacturing partner - preserving native vesicle architecture within a structured crystalline matrix. Instant dissolution in saline. Zero cryoprotectant additives. 12-month ambient shelf life.

Explore the ExoPearl™ format →
"Systemic administration of MSC-derived exosomes promotes neuroplasticity and neurological functional recovery. The microRNA cargo within exosomes is largely responsible for these therapeutic effects."
Frontiers in Cellular Neuroscience, 2024 - reviewing preclinical TBI and stroke models
Clinical Applications

Four emerging
protocols.

BEXO biologics are supplied to practitioners across four high-interest regenerative medicine indications, each supported by independent peer-reviewed evidence.

01
Systemic

IV Wellness & Longevity

Intravenous administration for regenerative wellness, anti-ageing, and immune modulation. For physician-supervised clinical use.

02
Dermatological

Hair Follicle Regeneration

Non-surgical alopecia protocols for dermatologists and trichologists. Among the most studied biologics for follicular regeneration.

03
Neurological

Neurorecovery & Nerve Repair

For neurologists and rehabilitation specialists in post-stroke recovery, TBI, and peripheral nerve repair.

04
Pain Management

Chronic Pain & Joint Restoration

For pain specialists and orthopaedic physicians targeting chronic musculoskeletal pain and osteoarthritis.

View full protocol details →
Product Catalogue

Three
formulations.

All BEXO products share the same ExoPearl™ core technology and quality standard, differentiated by concentration and clinical application.

Research / Cosmetic Grade
BEXO·CORE
Open access

2-sphere vial. ≥ 20 billion exosomes. Topical, intradermal, and scalp applications for dermatology and aesthetic practice.

Clinical Protocol Grade
BEXO·PRIME
Licensed practitioners

20-sphere vial. ≥ 200 billion exosomes. IV administration for longevity and regenerative medicine practices.

Neurological Specialist
BEXO·NEURO
Specialist access

3-sphere vial. ≥ 30 billion exosomes. Enriched neuroprotective cargo for stroke recovery, TBI, and nerve repair.

View full specifications & compare →
Scientific Foundation

Peer-reviewed
evidence.

The applications supported by BEXO biologics are grounded in independent published research.

30.8%
Absolute risk reduction in ARDS mortality
CHEST 2023 - Phase 2 RCT
0.7%
SAE rate across all EV clinical trials
NIH Meta-Analysis 2024
9.5–35
Hairs/cm² density gain in alopecia
PMC Systematic Review 2025
View all references & QC panel →
Access & Markets

Practitioner supply
& global reach.

BEXO operates a dual-access model - direct supply for licensed practitioners, and a practitioner-mediated pathway for individuals. Incorporated in Hong Kong SAR, shipping worldwide at ambient temperature via standard courier.

🇭🇰
Headquarters

Hong Kong SAR

Common law · Zero import duty · APAC gateway
🇪🇺
Europe

Europe & Western Balkans

Research-grade and cosmetic-grade supply
🌍
Worldwide

Global Distribution

Standard courier · 12-month shelf life · Any destination
Learn about access pathways & all markets →
Professional Account Application

Request access to BEXO biologics.

Licensed practitioners and verified research institutions are invited to apply for a wholesale account. Approval within 48 hours.

Wholesale PricingNo minimum order quantity. Volume discounts available.
Certificate of AnalysisFull COA with every shipment. Batch-level traceability.
Protocol & Reference PackPeer-reviewed guides and formulation documentation.
Dedicated Account SupportPersonal account manager for every partner.
Worldwide DeliveryStandard courier shipping. Room-temp stable.
BEXO ExoPearls™ are investigational research-grade biologics. Not approved therapeutic products. Supplied exclusively to licensed practitioners and research institutions under applicable local regulations.
Account Application

Applications reviewed within 48 hours. Credentials verified before activation.

For individual access enquiries, indicate your region and area of interest - we will connect you with a Partner Practitioner.